Cogent Biosciences (COGT) Consolidated Net Income (2017 - 2020)
Historic Consolidated Net Income for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.4 million.
- Cogent Biosciences' Consolidated Net Income fell 59478.49% to -$11.4 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$11.4 million, marking a year-over-year increase of 8334.77%. This contributed to the annual value of -$82.1 million for FY2020, which is 15713.7% down from last year.
- Per Cogent Biosciences' latest filing, its Consolidated Net Income stood at -$11.4 million for Q4 2020, which was down 59478.49% from -$57.2 million recorded in Q3 2020.
- In the past 5 years, Cogent Biosciences' Consolidated Net Income ranged from a high of $2.3 million in Q4 2019 and a low of -$57.2 million during Q3 2020
- For the 4-year period, Cogent Biosciences' Consolidated Net Income averaged around -$10.9 million, with its median value being -$8.0 million (2018).
- Per our database at Business Quant, Cogent Biosciences' Consolidated Net Income soared by 12676.83% in 2019 and then crashed by 59478.49% in 2020.
- Cogent Biosciences' Consolidated Net Income (Quarter) stood at -$6.8 million in 2017, then decreased by 26.77% to -$8.6 million in 2018, then skyrocketed by 126.77% to $2.3 million in 2019, then plummeted by 594.78% to -$11.4 million in 2020.
- Its Consolidated Net Income was -$11.4 million in Q4 2020, compared to -$57.2 million in Q3 2020 and -$7.4 million in Q2 2020.